In a case that is on track to be Philadelphia’s first trial over talc-related cancer, Johnson & Johnson has lost its bid to keep several experts from testifying about the alleged causal connection between talcum powder and ovarian cancer—a claim that has resulted in numerous so-called nuclear verdicts for injured women in other jurisdictions.
Philadelphia Judge Frederica Massiah-Jackson denied several motions J&J filed in the case, captioned Kleiner v. Rite Aid, that challenged methodologies used by six of the plaintiff’s experts to form their opinions that the company’s talcum powder causes cancer.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]